• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why NVIDIA Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

    5/23/24 8:39:23 AM ET
    $AKTS
    $ASTI
    $BNED
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Semiconductors
    Technology
    Get the next $AKTS alert in real time by email

    Shares of NVIDIA Corporation (NASDAQ:NVDA) rose sharply in today's pre-market trading after the company reported better-than-expected financial results for its first quarter and issued strong guidance for the second quarter.

    The company announced a 10-for-1 stock split and raised its quarterly dividend by 150%.

    NVIDIA shares jumped 6.3% to $1,008.80 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Ascent Solar Technologies, Inc. (NASDAQ:ASTI) rose 178.8% to $0.3660 in today's pre-market trading after jumping 19% on Wednesday.
    • iSpecimen Inc. (NASDAQ:ISPC) shares gained 44% to $0.4610 in pre-market trading after jumping around 32% on Wednesday.
    • Netcapital Inc. (NASDAQ:NCPL) gained 42.6% to $0.2169 in pre-market trading.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) gained 41.5% to $0.1115 in pre-market trading after jumping 34% on Wednesday.
    • Mustang Bio, Inc. (NASDAQ:MBIO) shares rose 18.8% to $0.2850 in pre-market trading after falling over 22% on Wednesday.
    • Sharps Technology, Inc. (NASDAQ:STSS) shares gained 14.8% to $0.2965 in pre-market trading.
    • LiveRamp Holdings, Inc. (NYSE:RAMP) shares climbed 14.4% to $37.00 in pre-market trading fter the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates. Also, the company issued FY25 revenue guidance with its midpoint above estimates.
    • SU Group Holdings Limited (NASDAQ:SUGP) gained 12.5% to $2.96 in pre-market trading.
    • Zuora, Inc. (NYSE:ZUO) gained 10.5% to $10.89 in pre-market trading after the company reported better-than-expected first-quarter sales results and issued FY25 adjusted EPS guidance above estimates.

    Losers

    • MGO Global, Inc. (NASDAQ:MGOL) shares declined 36.7% to $0.7340 in pre-market trading after dipping over 7% on Wednesday.
    • Barnes & Noble Education, Inc. (NYSE:BNED) shares declined 32.7% to $0.7601 in pre-market trading after jumping 109% on Wednesday. Greenhaven last week said it continues to explore a possible transaction with the company.
    • Akoustis Technologies, Inc. (NASDAQ:AKTS) shares dipped 32.3% to $0.2134 in pre-market trading after jumping over 128% on Wednesday. Akoustis announced a $10 million registered direct offering priced at-the-market under Nasdaq rules.
    • DermTech, Inc. (NASDAQ:DMTK) shares fell 20.2% to $0.3350 in pre-market trading after jumping 18% on Wednesday.
    • Roadzen, Inc. (NASDAQ:RDZN) shares fell 19.1% to $3.18 in pre-market trading after jumping around 20% on Wednesday.
    • V.F. Corporation (NYSE:VFC) shares declined 15.2% to $10.46 in pre-market trading following worse-than-expected fourth-quarter financial results. VF Corporation named Paul Vogel as Chief Financial Officer.
    • Exela Technologies, Inc. (NASDAQ:XELA) shares fell 14.7% to $2.37 in pre-market trading. Exela Technologies recently posted a first-quarter loss of $4.27 per share.
    • Cytokinetics, Incorporated (NASDAQ:CYTK) shares fell 14.7% to $50.55 in pre-market trading. Cytokinetics priced its public offering of 9,803,922 common stock at $51 per share.
    • MultiMetaVerse Holdings Limited (NASDAQ:MMV) fell 13.6% to $0.8192 in pre-market trading.
    • Nxu, Inc. (NASDAQ:NXU) shares fell 13.6% to $0.50 in pre-market trading. Nxu shares jumped 29% on Wednesday after the company was issued a vehicle technology patent.

    Now Read This: Nvidia, BJ’s Wholesale Club And 3 Stocks To Watch Heading Into Thursday

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $ASTI
    $BNED
    $CYTK

    CompanyDatePrice TargetRatingAnalyst
    Ascent Solar Technologies Inc.
    $ASTI
    4/23/2026$20.00Buy
    H.C. Wainwright
    V.F. Corporation
    $VFC
    4/14/2026$24.00Neutral → Buy
    Seaport Research Partners
    Cytokinetics Incorporated
    $CYTK
    4/10/2026$95.00Overweight
    Wells Fargo
    LiveRamp Holdings Inc.
    $RAMP
    3/24/2026$37.00Outperform
    Evercore ISI
    Aktis Oncology Inc.
    $AKTS
    3/9/2026$30.00Buy
    H.C. Wainwright
    V.F. Corporation
    $VFC
    2/23/2026$18.00Neutral → Underweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$30.00Overweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$34.00Buy
    BofA Securities
    More analyst ratings

    $AKTS
    $ASTI
    $BNED
    $CYTK
    SEC Filings

    View All

    Greenwave Technology Solutions Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Greenwave Technology Solutions, Inc. (0001589149) (Filer)

    4/22/26 4:20:17 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    SEC Form PRE 14A filed by Ascent Solar Technologies Inc.

    PRE 14A - Ascent Solar Technologies, Inc. (0001350102) (Filer)

    4/17/26 5:00:01 PM ET
    $ASTI
    Semiconductors
    Technology

    SEC Form DEF 14A filed by Cytokinetics Incorporated

    DEF 14A - CYTOKINETICS INC (0001061983) (Filer)

    4/17/26 4:05:43 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Barnes & Noble Education to Host Investor Day on June 25, 2026

    FLORHAM PARK, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Barnes & Noble Education, Inc. (NYSE:BNED), ("Barnes & Noble Education," "BNED," "the Company," "we," "us," "our"), a leading solutions provider for the education industry, today announced it will host a virtual Investor Day on Thursday, June 25, 2026, broadcast live from the New York Stock Exchange. During the event, BNED's leadership team will present a comprehensive overview of the Company's strategy, key growth drivers, and financial outlook. The presentation will highlight BNED's focus on improving affordability and outcomes for students, expanding its First Day® programs, and enhancing its omnichannel campus retail model to bett

    4/23/26 8:30:00 AM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Greenwave Announces Receipt of Non-Compliance Notice from Nasdaq

    Chesapeake, VA, April 22, 2026 (GLOBE NEWSWIRE) -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (NASDAQ:GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today reported that the Company received a notice (the "Notice") from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") on April 20, 2026, which indicated that because the Company has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K") with the U.S. Securities and Exchange Commission (the "SEC") by the applicable due date, the Company was not in compliance with Nasdaq Listing Rule 52

    4/22/26 4:15:00 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    Roadzen's UK Subsidiary, Global Insurance Management, Secures Several New Contracts Representing $2.5 Million in Projected Annual Revenue

    NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (NASDAQ:RDZN), a global leader in AI at the convergence of insurance and mobility, today announced that its wholly owned UK-based subsidiary, Global Insurance Management Limited ("GIM"), has closed several new commercial contracts that are collectively projected to contribute approximately $2.5 million in revenue over the coming twelve months. The contracts span a diverse range of partners across the automotive finance, dealer, and fleet sectors in the United Kingdom and internationally, with GIM providing two core product lines — connected vehicle protection and a suite of GAP Insurance solutions across these client relationships.

    4/22/26 8:45:00 AM ET
    $RDZN
    Specialty Insurers
    Finance

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Malhotra Rohan bought $26,146 worth of Ordinary Shares (19,085 units at $1.37), increasing direct ownership by 2% to 849,642 units (SEC Form 4)

    4 - Roadzen Inc. (0001868640) (Issuer)

    3/3/26 8:00:19 AM ET
    $RDZN
    Specialty Insurers
    Finance

    Director Foley Todd converted options into 4,002,533 shares and bought $4,191,660 worth of shares (232,870 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:20:21 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Mpm Bioventures 2018, L.P. converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:19:26 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Malik Fady Ibraham

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    4/21/26 4:22:13 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Gormley Glenn

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    4/16/26 4:15:09 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Gormley Glenn

    3 - Aktis Oncology, Inc. (0002035832) (Issuer)

    4/16/26 4:05:08 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on Ascent Solar with a new price target

    H.C. Wainwright initiated coverage of Ascent Solar with a rating of Buy and set a new price target of $20.00

    4/23/26 7:55:25 AM ET
    $ASTI
    Semiconductors
    Technology

    V.F. Corp upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded V.F. Corp from Neutral to Buy and set a new price target of $24.00

    4/14/26 8:13:41 AM ET
    $VFC
    Garments and Clothing
    Industrials

    Wells Fargo initiated coverage on Cytokinetics with a new price target

    Wells Fargo initiated coverage of Cytokinetics with a rating of Overweight and set a new price target of $95.00

    4/10/26 8:40:13 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Greenwave Technology Solutions Inc.

    SC 13G - Greenwave Technology Solutions, Inc. (0001589149) (Subject)

    12/5/24 10:00:25 AM ET
    $GWAV
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13D/A filed by Exela Technologies Inc.

    SC 13D/A - Exela Technologies, Inc. (0001620179) (Subject)

    12/3/24 4:01:40 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    SEC Form SC 13D filed by Exela Technologies Inc.

    SC 13D - Exela Technologies, Inc. (0001620179) (Subject)

    11/27/24 5:57:16 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Financials

    Live finance-specific insights

    View All

    Cytokinetics to Announce First Quarter Results on May 5, 2026

    SOUTH SAN FRANCISCO, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report first quarter results on May 5, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q1 2026 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics' websi

    4/21/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Netcapital Reports Third Quarter Fiscal 2026 Financial Results and Provides Corporate Update

    Key milestones include acquisition of Iverson Design and signing PureWave Hydrogen as first tokenization clientManagement to host business update conference call tomorrow at 10:00 am ET BOSTON, MA, March 19, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW, Netcapital)) (the "Company"), a digital private capital markets ecosystem, today announced financial results and provided corporate highlights for the third quarter of fiscal 2026 ended January 31, 2026. In addition, management plans to host a business update conference call tomorrow, March 20, 2026, at 10:00 a.m. ET. "We completed several key transactions in fiscal Q3 2026," said Rich Wheeless, Netcapital's Chief Executiv

    3/19/26 5:57:00 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2026

    Record quarterly revenue of $68.1 billion, up 20% from Q3 and up 73% from a year agoRecord quarterly Data Center revenue of $62.3 billion, up 22% from Q3 and up 75% from a year agoRecord full-year revenue of $215.9 billion, up 65% SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported record revenue for the fourth quarter ended January 25, 2026, of $68.1 billion, up 20% from the previous quarter and up 73% from a year ago. For fiscal 2026, revenue was $215.9 billion, up 65% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 75.0% and 75.2%, respectively. For fiscal 2026, GAAP and non-GAAP gross margins were 71.1% and

    2/25/26 4:31:17 PM ET
    $NVDA
    Semiconductors
    Technology

    $AKTS
    $ASTI
    $BNED
    $CYTK
    Leadership Updates

    Live Leadership Updates

    View All

    Netcapital Appoints Todd Violette as Chief Executive Officer

    BOSTON, MA, April 16, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW)) (the "Company"), a publicly traded fintech company that gives companies access to capital markets infrastructure without institutional-scale fees, today announced that its Board of Directors has appointed Mr. Violette to lead the Company in order to accelerate capital formation, expand platform reach, and build long-term shareholder value. Mr. Violette brings over 25 years of leadership experience across capital markets, fintech and digital asset-related businesses. His recent operating and executive roles have included CEO of CloudCover International, CEO of AppYea Inc., CEO of Vinergy, Chief Investment

    4/16/26 4:05:00 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

    BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced the appointment of Glenn Gormley, MD, PhD, as an independent director to its Board of Directors and co-chair of the Company's newly established Science and Technology Committee of the Board of Directors. "We are delighted to welcome Glenn to our Board as we continue to make significant progress toward upcoming clinical and corporate milestones," said Matthew Roden, PhD, President a

    4/16/26 8:00:00 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Later More Than Doubles Enterprise Business as Influencer Marketing Becomes a Performance Channel

    The company surpasses $2.9B in creator-driven commerce, appoints new CTO and expands AI capabilitiesBOSTON, April 14, 2026 /PRNewswire/ -- Later, the enterprise standard for influencer marketing and social commerce, today announces record performance milestones for Q1 2026. Fueled by strong enterprise momentum and a comprehensive rebrand launched at SXSW 2026, Later reported over 100% year-over-year growth in enterprise business for Q1 2026 as Fortune 500 brands consolidate their creator and social programs around a single, intelligent solution. Later now powers $2.9 billion in

    4/14/26 8:58:00 AM ET
    $RAMP
    EDP Services
    Technology